Sudarshan Pharma Industries543828Board meeting scheduled
Board meet on 29 October 2026 to consider and approve Q2/H1 results and a fund-raising proposal
Board meeting on Thursday, 29 October 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Thursday, 29 October 2026
- Results Period
- quarter and half year ended 30 September 2026
- Trading Window
- closed until 48 hours after the results are declared
Board meeting on 29 October 2026
- The company has informed BSE that a meeting of its Board of Directors is scheduled for Thursday, 29 October 2026.
- Two items are listed on the agenda, both to be considered and approved.
Agenda item 1 - financial results
- The Board will consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026.
- This covers the second quarter of the current financial year, and the consolidated set would combine the company with its subsidiaries.
Agenda item 2 - fund raising
- The Board will consider and approve a proposal for raising of funds.
- The funds may come in one or more instalments, through equity shares, convertible securities of any other description, warrants, or debt securities.
- The routes named are private placement, preferential issue, qualified institutions placement, or such other methods, or a combination of these.
- Any such fund raising would be subject to statutory and regulatory approvals as may be required.
Trading window
- The trading window of the company will remain closed until the expiry of 48 hours after the declaration of the financial results for the quarter and half year ended 30 September 2026.
What shareholders may watch for
- Results are a routine periodic disclosure and give a view of how the business performed in the September quarter.
- A fund raise can bring in fresh capital, and where equity shares or convertible instruments are issued, it can also change the number of shares and existing shareholders' percentage holding. The Board will decide the instruments and their terms when it meets.
- The trading window closure means designated persons connected with the company cannot deal in its shares until 48 hours after the results are made public, so that everyone in the market gets the information together.
Also from Sudarshan Pharma Industries
Board approves raising up to Rs.72,00,00,000 via convertible warrants to promoters
30 Oct 2026
Board approves proposal to issue up to 72,00,00,000 warrants to promoters on preferential basis
30 Oct 2026
Consolidated results for the quarter ended Sept 30, 2026
29 Oct 2026
More numbers
- Trading window closure after results are declared48 hours
Source: BSE · 26 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.